Skip to main content

Table 3 Hemodynamics assessment (mmHg)

From: Adiponectin reduces apoptosis of diabetic cardiomyocytes by regulating miR-711/TLR4 axis

  LVSP  + dp/dt −dp/dt LVEDP
C 126.03 ± 4.56 603.85 ± 6.59 623.03 ± 8.59 10.03 ± 0.91
D 103.26 ± 4.08 a 513.86 ± 10.06 a 430.48 ± 27.37 a 17.65 ± 1.74 a
DA 103.96 ± 3.85 a 514.01 ± 8.86 a 430.98 ± 25.58 a 16.98 ± 1.55 a
DMA 102.83 ± 5.02 a 510.43 ± 9.45 a 396.78 ± 28.12 a 17.02 ± 1.02 a
  1. C control, D diabetes, DA diabetes + adiponectin, DMA diabetes + miR-711 inhibitor + adiponectin, LVSP left ventricular systolic pressure, + dp/dt, the maximum rate of increase in left ventricular pressure, −dp/dt, the maximum rate of decrease in left ventricular pressure, LVEDP left ventricular end-diastolic pressure
  2. aP < 0.05, compared with the C group